Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | geranylgeranyl diphosphate synthase, putative | 0.0101 | 1 | 1 |
Giardia lamblia | Farnesyl diphosphate synthase | 0.0101 | 1 | 1 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0101 | 1 | 1 |
Trypanosoma cruzi | phosphoglycerate kinase, putative | 0.0092 | 0.8638 | 0.8638 |
Echinococcus multilocularis | farnesyl pyrophosphate synthase | 0.0101 | 1 | 1 |
Trypanosoma brucei | phosphoglycerate kinase | 0.0092 | 0.8638 | 0.8638 |
Trypanosoma brucei | phosphoglycerate kinase | 0.0092 | 0.8638 | 0.8638 |
Brugia malayi | Phosphoglycerate kinase | 0.0092 | 0.8638 | 0.8638 |
Trypanosoma cruzi | phosphoglycerate kinase, putative | 0.0092 | 0.8638 | 0.8638 |
Trypanosoma brucei | farnesyl pyrophosphate synthase | 0.0101 | 1 | 1 |
Entamoeba histolytica | phosphoglycerate kinase, putative | 0.0092 | 0.8638 | 0.5 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase, putative | 0.0101 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | phosphoglycerate kinase | 0.0092 | 0.8638 | 0.5 |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.0101 | 1 | 1 |
Echinococcus granulosus | farnesyl pyrophosphate synthase | 0.0101 | 1 | 1 |
Treponema pallidum | phosphoglycerate kinase | 0.0092 | 0.8638 | 0.5 |
Leishmania major | farnesyl pyrophosphate synthase | 0.0101 | 1 | 1 |
Plasmodium vivax | geranylgeranyl pyrophosphate synthase | 0.0101 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0101 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0101 | 1 | 1 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0101 | 1 | 1 |
Mycobacterium leprae | Probable phosphoglycerate kinase Pgk | 0.0092 | 0.8638 | 0.5 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase | 0.0101 | 1 | 1 |
Leishmania major | phosphoglycerate kinase C, glycosomal | 0.0092 | 0.8638 | 0.8638 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0101 | 1 | 1 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.0101 | 1 | 1 |
Leishmania major | phosphoglycerate kinase B, cytosolic | 0.0092 | 0.8638 | 0.8638 |
Chlamydia trachomatis | phosphoglycerate kinase | 0.0092 | 0.8638 | 0.5 |
Plasmodium falciparum | geranylgeranyl pyrophosphate synthase, putative | 0.0101 | 1 | 1 |
Schistosoma mansoni | farnesyl pyrophosphate synthase | 0.0101 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 100 uM | Antiviral activity against human cytomegalovirus(HCMV) by plaque reduction assay | ChEMBL. | 9548815 |
IC50 (functional) | > 100 uM | Antiviral activity against herpes simplex virus type-1 (HSV-1) | ChEMBL. | 9548815 |
IC50 (functional) | > 100 uM | Visual cytotoxicity scored on HFF cells at a time of HCMV plaque enumeration | ChEMBL. | 9548815 |
IC50 (functional) | > 100 uM | Inhibition of KB cell growth determined by quadruplicate assays | ChEMBL. | 9548815 |
IC50 (functional) | > 100 uM | Activity against HIV-1 by syncytial plaque assay performed in duplicate using CEM-SS cells | ChEMBL. | 9548815 |
IC50 (functional) | > 100 uM | Cytotoxicity against CEM-SS cells in terms of incorporation of [3H]-dThd | ChEMBL. | 9548815 |
IC50 (functional) | > 100 uM | Visual cytotoxicity scored on HFF cells at a time of HCMV plaque enumeration | ChEMBL. | 9548815 |
IC50 (functional) | > 100 uM | Inhibition of KB cell growth determined by quadruplicate assays | ChEMBL. | 9548815 |
IC50 (functional) | > 100 uM | Cytotoxicity against CEM-SS cells in terms of incorporation of [3H]-dThd | ChEMBL. | 9548815 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.